Stock comparison

ALNYvsNTRA

Alnylam Pharmaceuticals IncvsNatera Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

ALNY

Alnylam Pharmaceuticals Inc

$313.79

-19.78%

Biotechnology$41.4BNASDAQ

NTRA

Natera Inc

$201.14

-11.94%

Biotechnology$28.0BNASDAQ

60-day price, rebased to 100

ALNY -7.18% · NTRA -13.11%

Round-by-round

ALNY 5·NTRA 1

EdgeALNY

Valuation upside

-30.50% vs -67.20% to DCF fair value

EdgeNTRA

Balance-sheet strength

Altman Z 5.77 vs 23.91

EdgeALNY

Fundamental quality

Piotroski 6.00 vs 5.00 (of 9)

EdgeALNY

Growth + margins

Rule-of-40 77.70 vs 39.20

EdgeALNY

60-day momentum

-7.18% vs -13.11% price return

EdgeALNY

Market-cap liquidity

$41.4B vs $28.0B

Verdict

Across6categories,ALNYtakes the edge with5wins to1. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onALNYorNTRA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.